SERIOUSLY COOL CARS WITH EXCEPTIONAL PROVENANCE AT BROAD ARROW’S 2026 ZOUTE LIVE AND ONLINE AUCTIONS

Broad Arrow’s Zoute Concours Auction takes place on Friday 9 October in collaboration with the prestigious Zoute Grand Prix Car Week, closely following by Global Icons: Zoute Online, open for bidding 5-14 October at broadarrowauctions.com | Final highlights for 9 October Zoute Concours Auction led by one-of-one 2000 BMW M5 Volkswagen W10 Prototype, commissioned and driven by Ferdinand Piëch | 1955 Mercedes-Benz 300 SL Gullwing Coupé, one of the best preserved, unrestored examples in the world also joins Zoute Concours Auction lineup | Period-correct Porsche Renntransporter tribute in Global Icons: Zoute Online auction presents rare opportunity to enhance any motorsport collection | Complete digital catalogue for the Zoute Concours Auction along with information on all cars set for Global Icons: Zoute Online available at broadarrowauctions.com

Broad Arrow’s Zoute Concours Auction takes place on Friday 9 October in collaboration with the prestigious Zoute Grand Prix Car Week, closely following by Global Icons: Zoute Online, open for bidding 5-14 October at broadarrowauctions.com | Final highlights for 9 October Zoute Concours Auction led by one-of-one 2000 BMW M5 Volkswagen W10 Prototype, commissioned and driven by Ferdinand Piëch | 1955 Mercedes-Benz 300 SL Gullwing Coupé, one of the best preserved, unrestored examples in the world also joins Zoute Concours Auction lineup | Period-correct Porsche Renntransporter tribute in Global Icons: Zoute Online auction presents rare opportunity to enhance any motorsport collection | Complete digital catalogue for the Zoute Concours Auction along with information on all cars set for Global Icons: Zoute Online available at broadarrowauctions.com

Liveteq LLC Introduces Songer AI Music Generator for Text-to-Song Creation

CHEYENNE, WY, Sept. 24, 2026 (GLOBE NEWSWIRE) — Liveteq LLC has introduced Songer, an AI music generator that converts written prompts into complete songs combining vocals and instrumental arrangements. The platform is designed for musicians, songwriters, producers, content creators and hobbyists seeking a way to develop music from plain-language ideas without requiring an instrument or studio booking as part of the creation process.

Zymeworks Completes Acquisition of Theravance Biopharma

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisition of Theravance Biopharma. With the completion of the transaction, Theravance Biopharma is now part of Zymeworks, further advancing Zymeworks’ strategy to build a diversified revenue-generating biotechnology company, combining innovative R&D with growing commercial and royalty-based cash flows.

Following National Advertising Division Inquiry, Guardian Voluntarily Modifies “40% Off” Savings and Strikethrough Pricing Claims

Following an inquiry brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, Syscend, Inc. d/b/a Guardian Bikes modified certain advertising claims and practices concerning its children’s and adult bicycles, including savings claims, strikethrough pricing, limited-time sale language, and consecutive countdown timers.

Following an inquiry brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, Syscend, Inc. d/b/a Guardian Bikes modified certain advertising claims and practices concerning its children’s and adult bicycles, including savings claims, strikethrough pricing, limited-time sale language, and consecutive countdown timers.

ITM and Lumara Bio Announce Upcoming Dosimetry and Re-treatment Data Presentations on ¹⁷⁷Lu-edotreotide at ASTRO 2026

Garching / Munich, September 23, 2026 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Lumara Bio, a dedicated oncology therapeutics division of ITM, today announced that they will provide new data for Lu-edotreotide (ITM-11) in two poster presentations at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, held from September 26 – 30, 2026 in Boston, Massachusetts. One poster will feature Phase 3 COMPETE trial dosimetry results for 177Lu-edotreotide in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A second poster will highlight findings from a registry analysis of re-treatment with 177Lu-edotreotide in patients with progressive neuroendocrine tumors (NETs).